Dermapharm Holding SE (ETR: DMP)

Market Cap	2.17B
Revenue (ttm)	1.17B
Net Income (ttm)	90.59M
Shares Out	53.84M
EPS (ttm)	1.68
PE Ratio	24.03
Forward PE	17.62
Dividend	0.88 (2.18%)
Ex-Dividend Date	Jun 28, 2024

Volume	18,245
Average Volume	34,615
Open	40.40
Previous Close	40.35
Day's Range	39.80 - 40.40
52-Week Range	30.15 - 41.85
Beta	1.10
RSI	61.61
Earnings Date	Mar 14, 2025

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,497
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DMP

Financial Performance

In 2023, Dermapharm Holding SE's revenue was 1.15 billion, an increase of 10.59% compared to the previous year's 1.04 billion. Earnings were 62.37 million, a decrease of -53.54%.